Drug intelligence / Profile preview

Shanghai Jenomed Biotech personalized cancer vaccine

Development stage
Preclinical
Lead developer
Shanghai Jenomed Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Injection
01

Overview

Shanghai Jenomed Biotech is developing a preclinical-stage personalized cancer vaccine (PCV) platform. The technology involves identifying tumor-specific neoantigens from circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) using whole exome sequencing (WES) and RNA sequencing (RNA-seq). These identified neoantigens are then incorporated into a customized vaccine designed to stimulate a patient-specific anti-tumor immune response. Preclinical studies in mouse models have demonstrated the platform's potential in treating lung cancer, skin cancer, and liver cancer.

Other names
PCVpersonalized cancer vaccineneoantigen vaccine
02

Targets

pMHC-I (Peptide–MHC class I complex)

Beyond the preview

Go deeper on Shanghai Jenomed Biotech personalized cancer vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Jenomed Biotech personalized cancer vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call